| 产品详情 |
| Edit |   |
| Product Name | 14(15)-EET Ethanolamide |
| Description | Purity >95%. Arachidonyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1 ) and peripheral cannabinoid (CB2 ) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the hydrolysis and inactivation of AEA. Metabolism of AEA by cyclooxygenase-2, leading to formation of prostaglandin ethanolamides, and by lipoxygenases has also been documented. (±)14(15)-EET ethanolamide is a potential cytochrome P450 (CYP450) metabolite of arachidonoyl ethanolamide (AEA), although specific stereochemistry rather than a racemic mixture would likely ensue from enzymatic metabolism. CYP450 metabolism of AEA may be particularly relevant under conditions of fatty acid amide hydrolase inhibition. Evidence for the formation of (±)14(15)-EET ethanolamide in vivo has not been documented. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | N-(2-hydroxyethyl)-(±)14(15)-epoxy-5Z,8Z,11Z-eicosatrienamide, (±)14(15)-Epoxy Eicosatrienoyl Ethanolamide, (±)14,15-EpETrE Ethanolamide |
| Gene, Accession, CAS # | n/a |
| Catalog # | LS-H5830 |
| Price | |
| Order / More Info | 14(15)-EET Ethanolamide from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|